Cefprozil for Oral Suspension USP, 250mg/5mL, packaged as a) 50 mL (when mixed) bottles (NDC 68180-402-01); b) 75 mL (when mixed) bottles (NDC 68180-402-02); and c) 100 mL (when mixed) bottles (NDC 68180-402-03); Rx only, Manufactured for: Lupin Pharmaceutical, Inc., Baltimore, MD 21202; Manufactured by: Lupin Limited, Mandideep 462 046, India.

This recall has been terminated (originally issued April 21, 2021).

Company

Lupin Pharmaceuticals Inc.

Recall Initiated

March 26, 2021

Posted

April 21, 2021

Recall Number

D-0332-2021

Voluntary / Mandated

Voluntary: Firm initiated

Quantity

a) 6,816 bottles; b) 3,960 bottles and c) 7,038 bottles

Firm Location

Baltimore, MD, United States

Official Source

View on FDA website ↗